We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
-14.46%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.39B
AUM Growth
-$242M
Cap. Flow
+$1.44M
Cap. Flow %
0.1%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$1.44M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 55.42%
2 Consumer Staples 26.82%
3 Miscellaneous 10.21%
4 Industrials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.13B
$687M 49.5%
8,592,007
– –
MNST icon
2
Monster Beverage
MNST
$87.7B
$372M 26.82%
18,625,952
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$77.2B
$142M 10.21%
690,000
– –
AXON
4
Axon Enterprise
AXON
$38.4B
$105M 7.55%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$266M
$53.8M 3.88%
34,935,485
+930,106
+3% +$1.44M
IMDX
6
Insight Molecular Diagnostics
IMDX
$125M
$25.9M 1.86%
867,497
– –
SER icon
7
Serina Therapeutics
SER
$58.2M
$2.56M 0.18%
85,219
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Broadwood Capital held 7 positions worth $1.39B, down 15% from $1.63B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 56% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q1 2022, an estimated $1.44M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.39B portfolio in Q1 2022.
  • Broadwood Capital opened 0 new positions and closed 0 in Q1 2022.
  • Broadwood Capital's portfolio value fell 15% quarter-over-quarter to $1.39B.

Based on Broadwood Capital's 13F filing for Q1 2022, filed 16 May 2022.